mefenamic acid has been researched along with Premenstrual Syndrome in 7 studies
Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study aimed to compare the effects of Chamomile Extract and Mefenamic acid (MA) on the intensity of Premenstrual syndrome (PMS) symptoms." | 9.19 | Comparison of the effects of Matricaria chamomila (Chamomile) extract and mefenamic acid on the intensity of premenstrual syndrome. ( Majd, HA; Mojab, F; Sharifi, F; Simbar, M, 2014) |
| "The use of mefenamic acid in the treatment of premenstrual syndrome (PMS) was investigated in 15 women over six menstrual cycles." | 9.06 | Mefenamic acid in the treatment of premenstrual syndrome. ( Abraham, S; Fraser, IS; McNeil, D; Mira, M; Vizzard, J, 1986) |
| "Eighty patients with premenstrual tension were treated prospectively with mefenamic acid for a mean period of 13 months." | 9.05 | The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations. ( Dewhurst, J; Godard, E; Jakubowicz, DL, 1984) |
| "Mefenamic acid or placebo was taken on days 11-26 of the cycle in a prospectively randomized double-blind cross-over manner, with each patient acting as her own control." | 6.66 | Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid. ( Gunston, KD, 1986) |
| "The study aimed to compare the effects of Chamomile Extract and Mefenamic acid (MA) on the intensity of Premenstrual syndrome (PMS) symptoms." | 5.19 | Comparison of the effects of Matricaria chamomila (Chamomile) extract and mefenamic acid on the intensity of premenstrual syndrome. ( Majd, HA; Mojab, F; Sharifi, F; Simbar, M, 2014) |
| "The use of mefenamic acid in the treatment of premenstrual syndrome (PMS) was investigated in 15 women over six menstrual cycles." | 5.06 | Mefenamic acid in the treatment of premenstrual syndrome. ( Abraham, S; Fraser, IS; McNeil, D; Mira, M; Vizzard, J, 1986) |
| "Eighty patients with premenstrual tension were treated prospectively with mefenamic acid for a mean period of 13 months." | 5.05 | The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations. ( Dewhurst, J; Godard, E; Jakubowicz, DL, 1984) |
| "Mefenamic acid or placebo was taken on days 11-26 of the cycle in a prospectively randomized double-blind cross-over manner, with each patient acting as her own control." | 2.66 | Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid. ( Gunston, KD, 1986) |
| " The dosage of mefenamic acid was 500 mg thrice daily." | 2.65 | The treatment of premenstrual symptoms with mefenamic acid. ( Jakubowicz, D; Wood, C, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sharifi, F | 1 |
| Simbar, M | 1 |
| Mojab, F | 1 |
| Majd, HA | 1 |
| Jakubowicz, DL | 1 |
| Godard, E | 1 |
| Dewhurst, J | 1 |
| Wood, C | 1 |
| Jakubowicz, D | 1 |
| Nader, S | 1 |
| McMurchie, M | 1 |
| Hindmarsh, E | 1 |
| Mira, M | 1 |
| McNeil, D | 1 |
| Fraser, IS | 1 |
| Vizzard, J | 1 |
| Abraham, S | 1 |
| Gunston, KD | 1 |
5 trials available for mefenamic acid and Premenstrual Syndrome
| Article | Year |
|---|---|
Comparison of the effects of Matricaria chamomila (Chamomile) extract and mefenamic acid on the intensity of premenstrual syndrome.
Topics: Adolescent; Adult; Double-Blind Method; Female; Humans; Matricaria; Mefenamic Acid; Phytotherapy; Pl | 2014 |
The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dinoprost; Dinoprostone; Double-Blind Method; Female; H | 1984 |
The treatment of premenstrual symptoms with mefenamic acid.
Topics: Adult; Breast Diseases; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Mefenamic Aci | 1980 |
Mefenamic acid in the treatment of premenstrual syndrome.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Mefenamic Acid; Menstrual Cycl | 1986 |
Premenstrual syndrome in Cape Town. Part II. A double-blind placebo-controlled study of the efficacy of mefenamic acid.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Mefenamic Acid; Premenstrual Syndrome | 1986 |
2 other studies available for mefenamic acid and Premenstrual Syndrome
| Article | Year |
|---|---|
Premenstrual syndrome. Tailoring treatment to symptoms.
Topics: Bromocriptine; Contraceptives, Oral; Danazol; Diuretics; Female; Gonadotropin-Releasing Hormone; Hum | 1991 |
Premenstrual syndrome. A general practice view.
Topics: Contraceptives, Oral; Female; Humans; Life Style; Mefenamic Acid; Premenstrual Syndrome; Pyridoxine; | 1989 |